Efficacy and safety of remifentanil dose titration to correct the spontaneous hyperventilation in aneurysmal subarachnoid haemorrhage: protocol and statistical analysis for a prospective physiological study

Rui Su, Jianfang Zhou, Ning Zhu, Xiaolin Chen, Jian-Xin Zhou, Hong-Liang Li, Rui Su, Jianfang Zhou, Ning Zhu, Xiaolin Chen, Jian-Xin Zhou, Hong-Liang Li

Abstract

Introduction: Spontaneous hyperventilation (SHV) is common in aneurysmal subarachnoid haemorrhage (aSAH). The reduction in arterial partial pressure of carbon dioxide (PaCO2) may change the brain physiology, such as haemodynamics, oxygenation, metabolism and may lead to secondary brain injury. However, how to correct SHV safely and effectively in patients with aSAH has not been well investigated. The aim of this study is to investigate the efficacy and safety of remifentanil dose titration to correct hyperventilation in aSAH, as well as the effect of changes in PaCO2 on cerebral blood flow (CBF).

Methods and analysis: This study is a prospective, single-centre, physiological study in patients with aSAH. The patients who were mechanically ventilated and who meet with SHV (tachypnoea combined with PaCO2 <35 mm Hg and pH >7.45) will be enrolled. The remifentanil will be titrated to correct the SHV. The predetermined initial dose of remifentanil is 0.02 μg/kg/min and will be maintained for 30 min, and PaCO2 and CBF will be measured. After that, the dose of remifentanil will be sequentially increased to 0.04, 0.06, and 0.08 μg/kg/min, and the measurements for PaCO2 and CBF will be repeated 30 min after each dose adjustment and will be compared with their baseline values.

Ethics and dissemination: This study has been approved by the Institutional Review Board of Beijing Tiantan Hospital, Capital Medical University (KY 2021-006-02) and has been registered at ClinicalTrials.gov. The results of this study will be disseminated through peer-reviewed publications and conference presentations.

Trial registration number: NCT04940273.

Keywords: adult intensive & critical care; stroke.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow chart of the study procedure.
Figure 2
Figure 2
Upward titration of remifentanil during experimental intervention.

References

    1. Solaiman O, Singh JM. Hypocapnia in aneurysmal subarachnoid hemorrhage: incidence and association with poor clinical outcomes. J Neurosurg Anesthesiol 2013;25:254–61. 10.1097/ANA.0b013e3182806465
    1. Williamson CA, Sheehan KM, Tipirneni R, et al. . The association between spontaneous hyperventilation, delayed cerebral ischemia, and poor neurological outcome in patients with subarachnoid hemorrhage. Neurocrit Care 2015;23:330–8. 10.1007/s12028-015-0138-5
    1. Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 1985;62:59–67. 10.3171/jns.1985.62.1.0059
    1. Schmieder K, Jarus-Dziedzic K, Wronski J, et al. . Co2 reactivity in patients after subarachnoid haemorrhage. Acta Neurochir 1997;139:1038–41. 10.1007/BF01411557
    1. Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med 2010;38:1348–59. 10.1097/CCM.0b013e3181d8cf2b
    1. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am J Physiol Regul Integr Comp Physiol 2009;296:R1473–95. 10.1152/ajpregu.91008.2008
    1. Raichle ME, Posner JB, Plum F. Cerebral blood flow during and after hyperventilation. Arch Neurol 1970;23:394–403. 10.1001/archneur.1970.00480290014002
    1. Raichle ME, Plum F. Hyperventilation and cerebral blood flow. Stroke 1972;3:566–75. 10.1161/01.STR.3.5.566
    1. Westermaier T, Stetter C, Kunze E, et al. . Controlled hypercapnia enhances cerebral blood flow and brain tissue oxygenation after aneurysmal subarachnoid hemorrhage: results of a phase 1 study. Neurocrit Care 2016;25:205–14. 10.1007/s12028-016-0246-x
    1. Natalini G, Di Maio A, Rosano A, et al. . Remifentanil improves breathing pattern and reduces inspiratory workload in tachypneic patients. Respir Care 2011;56:827–33. 10.4187/respcare.01014
    1. Costa R, Navalesi P, Cammarota G, et al. . Remifentanil effects on respiratory drive and timing during pressure support ventilation and neurally adjusted ventilatory assist. Respir Physiol Neurobiol 2017;244:10–16. 10.1016/j.resp.2017.06.007
    1. Cavaliere F, Antonelli M, Arcangeli A, et al. . A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patients. Can J Anaesth 2002;49:1088–94. 10.1007/BF03017909
    1. Ruggeri L, Landoni G, Guarracino F, et al. . Remifentanil in critically ill cardiac patients. Ann Card Anaesth 2011;14:6–12. 10.4103/0971-9784.74393
    1. Epstein Y, Druyan A, Heled Y. Heat injury prevention--a military perspective. J Strength Cond Res 2012;26 Suppl 2:S82–6. 10.1519/JSC.0b013e31825cec4a
    1. Connolly ES, Rabinstein AA, Carhuapoma JR, et al. . Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American heart Association/american stroke association. Stroke 2012;43:1711–37. 10.1161/STR.0b013e3182587839
    1. Ely EW, Truman B, Shintani A, et al. . Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation scale (RASS). JAMA 2003;289:2983–91. 10.1001/jama.289.22.2983
    1. Kotfis K, Zegan-Barańska M, Szydłowski Łukasz, et al. . Methods of pain assessment in adult intensive care unit patients - Polish version of the CPOT (Critical Care Pain Observation Tool) and BPS (Behavioral Pain Scale). Anaesthesiol Intensive Ther 2017;49:66–72. 10.5603/AIT.2017.0010
    1. , Brower RG, Matthay MA, et al. , Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–8. 10.1056/NEJM200005043421801
    1. Telias I, Junhasavasdikul D, Rittayamai N, et al. . Airway occlusion pressure as an estimate of respiratory drive and inspiratory effort during assisted ventilation. Am J Respir Crit Care Med 2020;201:1086–98. 10.1164/rccm.201907-1425OC
    1. Stetter C, Weidner F, Lilla N, et al. . Therapeutic hypercapnia for prevention of secondary ischemia after severe subarachnoid hemorrhage: physiological responses to continuous hypercapnia. Sci Rep 2021;11:11715. 10.1038/s41598-021-91007-7
    1. Valdueza JM, Balzer JO, Villringer A, et al. . Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: assessment with Mr and transcranial Doppler sonography. AJNR Am J Neuroradiol 1997;18:1929–34.
    1. Westermaier T, Stetter C, Kunze E, et al. . Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage? J Neurosurg 2014;121:1056–62. 10.3171/2014.7.JNS132611
    1. Lindegaard KF, Nornes H, Bakke SJ, et al. . Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl 1988;42:81–4. 10.1007/978-3-7091-8975-7_16
    1. Giller CA. A bedside test for cerebral autoregulation using transcranial Doppler ultrasound. Acta Neurochir 1991;108:7–14. 10.1007/BF01407660
    1. Smielewski P, Czosnyka M, Kirkpatrick P, et al. . Assessment of cerebral autoregulation using carotid artery compression. Stroke 1996;27:2197–203. 10.1161/01.STR.27.12.2197
    1. Al-Jehani H, Angle M, Marcoux J, et al. . Early abnormal transient hyperemic response test can predict delayed ischemic neurologic deficit in subarachnoid hemorrhage. Crit Ultrasound J 2018;10:1. 10.1186/s13089-017-0079-7
    1. Marcolini E, Stretz C, DeWitt KM. Intracranial hemorrhage and intracranial hypertension. Emerg Med Clin North Am 2019;37:529–44. 10.1016/j.emc.2019.04.001
    1. Report of World Federation of neurological surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988;68:985–6. 10.3171/jns.1988.68.6.0985
    1. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20. 10.3171/jns.1968.28.1.0014
    1. Frontera JA, Claassen J, Schmidt JM, et al. . Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery 2006;59:21–7. 10.1227/01.NEU.0000218821.34014.1B
    1. Knaus WA, Draper EA, Wagner DP, et al. . Apache II: a severity of disease classification system. Crit Care Med 1985;13:818–29.
    1. Vincent JL, de Mendonça A, Cantraine F, et al. . Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793–800. 10.1097/00003246-199811000-00016
    1. Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin scale and its use in future stroke trials. Stroke 2017;48:2007–12. 10.1161/STROKEAHA.117.017866
    1. Pauwels RA, Buist AS, Calverley PM, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (gold) workshop summary. Am J Respir Crit Care Med 2001;163:1256–76. 10.1164/ajrccm.163.5.2101039
    1. Marshall SA, Nyquist P, Ziai WC. The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010;21:291–303. 10.1016/j.nec.2009.10.010
    1. Frontera JA, Fernandez A, Schmidt JM, et al. . Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009;40:1963–8. 10.1161/STROKEAHA.108.544700
    1. Coles JP, Fryer TD, Coleman MR, et al. . Hyperventilation following head injury: effect on ischemic burden and cerebral oxidative metabolism. Crit Care Med 2007;35:568–78. 10.1097/01.CCM.0000254066.37187.88
    1. Coles JP, Minhas PS, Fryer TD, et al. . Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates. Crit Care Med 2002;30:1950–9. 10.1097/00003246-200209000-00002
    1. Karabinis A, Mandragos K, Stergiopoulos S, et al. . Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004;8:R268–80. 10.1186/cc2896
    1. Hoiland RL, Fisher JA, Ainslie PN. Regulation of the cerebral circulation by arterial carbon dioxide. Compr Physiol 2019;9:1101–54. 10.1002/cphy.c180021
    1. Akkermans A, van Waes JA, Peelen LM, et al. . Blood pressure and end-tidal carbon dioxide ranges during aneurysm occlusion and neurologic outcome after an aneurysmal subarachnoid hemorrhage. Anesthesiology 2019;130:92–105. 10.1097/ALN.0000000000002482

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅